Company
BetaGlue Technologies is a highly innovative clinical stage company targeting solid tumors and surgical resection margins with a proprietary β-emitting bio-compatible matrix, delivered to target via a dedicated delivery system; both components are cleared as medical devices, benefitting of a shorter regulatory pathway.
The team is supported by a highly qualified Scientific Advisory Board, as well as by national/international consultants on product development, intellectual property and regulatory expertise.
Management Team
Chief Executive Officer
ANTONINO AMATO,
MD
Former Corporate Development Director, Sigma-Tau Pharmaceuticals, Rome
Former Director, Clinical Trial Center, Policlinico Gemelli, Rome
Chief Financial Officier
GIOVANNI PARISIO,
MBA
Former CFO of multinational, listed and financial companies.
Extensive experience in seed capital VC
VP, Product Development
JASON SCHENSE, PHD
Former CTO of Kuros Biosciences AG.
Extensive experience in product development in USA and EUR
VP, Clinical Operations
PIER LUIGI CARRIERO, MD
Long-standing experience in pharma and CRO companies
Board of Directors
RICCARDO PALMISANO, MD
Executive Chairman
ANTONINO AMATO, MD – CEO
Former Product Development Director, SIGMA-TAU (Rome, Italy)
Former Director, CTC Policlinico Gemelli, Rome (Italy)
Former Director, CTC Policlinico Gemelli, Rome (Italy)
DIANA SARACENI, MS – Designated Panakès
Co-founder and Managing Partner PANAKES PARTNERS
Former Co-founder and Managing Partner 360 CAPITAL
Former Co-founder and Managing Partner 360 CAPITAL
CLAUDIO GIULIANO, MS – Designated Innogest
Founder and CEO, INNOGEST CAPITAL
Former Vice President, The Carlyle Group
Former Vice President, The Carlyle Group
GEOFFROY DE RIBAINS, MS – Independent Director
Entrepreneur in residence, Advent France
Former Co-founder and CEO, Step Pharma
Former Co-founder and CEO, Step Pharma
Scientific Advisors
ROBERTO CIANNI, MD – Int. Radiologist
Chair of Interventional Radiology, San Camillo Hospital, Rome
GIUSEPPE ETTORRE, MD – HPB Surgeon
Chair of HPB and General Surgery, San Camillo Hospital, Rome
RICCARDO MASETTI, MD – Breast Surgeon
Chair of Breast Surgery, Fondazione Gemelli, Rome (IRCCS) Prof. Surgery, Catholic University, Rome President, Komen Foundation Italy
GORDON MC VIE, MD – Oncologist
in memoriam
Consultant, London
Past Joint Director General – Cancer Research UK
Past Joint Director General – Cancer Research UK
GIOVANNI PAGANELLI, MD – Nuclear Medicine
Chair Nuclear Medicine, IRST, Meldola (IRCCS)
Prof. Nuclear Medicine, Univ. of Ferrara
Prof. Nuclear Medicine, Univ. of Ferrara
VINCENZO VALENTINI, MD – Radiotherapist
Chair of Radiation Oncology, Fondazione Gemelli, Rome (IRCCS)
Prof. Radiology, Catholic University, Rome
Past President, Eur Society Radiation Oncology (ESTRO)
Prof. Radiology, Catholic University, Rome
Past President, Eur Society Radiation Oncology (ESTRO)
Main Consultants
GIOVANNI PAGANELLI, MD – Irst Meldola
Nuclear medicine
ENRICO PERFLER, MS – 1Med
Clinical studies, regulatory affairs EUR, CE mark
MARIA E. DONAWA, MD – Donawa Lifescience
Regulatory affairs – FDA
WALTER WU, MD – Dorsey and Whitney
Intellectual property
MARIA LAURA COSTANTINO, PhD – Politecnico di Milano
Product development – Devices
CHRIS FLAHERTY, PhD – Aheebuild
Intellectual Property
Contact us
